Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

Indian share markets soar higher
Tue, 5 Mar 01:30 pm

Backed by all-round buying, Indian share markets continued to ascend in the post-noon trading session. Barring consumer durables, all sectoral indices are trading positive with metal, auto and realty stocks being the top gainers.

BSE-Sensex is up 196 points and NSE-Nifty is trading up by 65 points. While BSE Mid Cap is up 1.1%, BSE Small Cap index is trading up by 0.5%. The rupee is trading at 54.6 to the US dollar.

Majority of pharma stocks are trading in green, with Natco Pharma and Strides Acrolab among the leading gainers. As per a leading financial daily, couple of weeks back Ranbaxy had announced about restarting supply of generic Lipitor in US. This was after USFDA authorities had directed for the recall of the drug, which was manufactured in Mohali facility in India. However it is pertinent to note that company is allowed for manufacturing generic Lipitor from its Ohm facility in US. Reportedly, the company is still awaiting green signal from the regulators to resume manufacturing of atorvastatin (Lipitor generics) at its Mohali facility in India. This facility is a newly built SEZ facility and had commenced export of atorvastatin drug since April 2012. In Dec 2012, the company had recalled drug due to presence of glass particles. Thus though company has reinitiated the supply of atorvastatin, it is working with USFDA and has identified and implemented on corrective measures.

Most of the automobile stocks are trading in green with Tata Motors and Maruti Suzuki leading in gains. However, Bajaj Auto and Maharashtra Scooters are trading in red. As per a leading financial daily, Jaguar Land Rover (JLR) owned by Tata Motors has planned to raise investment at its UK engine plant from 350 m pounds to 500 m pounds. This hike is part of JLR's plans to scale up capital spending significantly in its production facilities. JLR has been able to offset plant shutdowns and falling production in the European auto market through rising demand for its luxury saloons and Sports Utility Vehicles in China and other emerging markets. Therefore, JLR in local partnership is building a factory in China. The company is also investigating the potential of manufacturing cars in India.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets soar higher". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited).

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Research Private Limited (formerly Equitymaster Agora Research Private Limited) (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.